Ticker Details
Kyverna Therapeutics, Inc. Common Stock
IPO Date:	February 9, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$457.78M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.34 | 4.51%
Avg Daily Range (30 D):	$0.38 | 4.44%
Avg Daily Range (90 D):	$0.40 | 5.00%

Institutional Daily Volume
Avg Daily Volume:	.52M
Avg Daily Volume (30 D):	.72M
Avg Daily Volume (90 D):	1.15M

Trade Size
Avg Trade Size (Sh.):	101
Avg Trade Size (Sh.) (30 D):	90
Avg Trade Size (Sh.) (90 D):	99

Institutional Trades
Total Institutional Trades:	141
Avg Institutional Trade:	$1.8M
Avg Institutional Trade (30 D):	$.67M
Avg Institutional Trade (90 D):	$1.55M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.39M
Avg Closing Trade (30 D):	$.68M
Avg Closing Trade (90 D):	$.88M
Avg Closing Volume:	237.89K

News

Feb 24, 2026 @ 1:00 PM Kyverna Therapeutics Appoints Biotech Leaders Srav... Source: Na

Dec 31, 2025 @ 3:01 PM How M&A Unlocked A Biotech Rebound In 2025—... Source: Namrata Sen

Dec 17, 2025 @ 2:24 PM Kyverna Therapeutics Announces Pricing of $100 Mil... Source: Globe Newswire

Dec 15, 2025 @ 11:20 PM Stock Market Today, Dec. 15: U.S Stocks Ease as In... Source: Eric Trie

Dec 14, 2025 @ 7:30 PM Kyverna Therapeutics to Report Topline Results fro... Source: Kyverna Therapeutics

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.73	$-.85	$-.97
Diluted EPS	$-3.73	$-.85	$-.97
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-160.99M	$-36.79M	$-42.08M
Operating Income / Loss	$-171.59M	$-38.73M	$-44.41M
Cost of Revenue
Net Cash Flow	$-70.51M	$-19.28M	$-3.43M
PE Ratio